Showing results (31-40 of 266) with videos related to
Sort By:
Pageof 27
Human Immunology|April 25, 2000
A novel HLA-B*39 allele (HLA-B*3916) due to a rare mutation causing cryptic splice site activationR Tamouza, N El Kassar, V Schaeffer, et al.International Immunology|July 6, 2000
Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patientsL Guilherme, N Dulphy, C Douay, et al.Tissue Antigens|July 30, 2002
Two novel CD1 E alleles identified in black African individualsR Tamouza, R Sghiri, R Ramasawmy, et al.Bulletin Du Cancer|September 1, 1993
[Demonstration of transcriptional regulation of protein kinase C by class II anti-HLA antibodies in human CA cells of the lymphoblastoid line]C Brick-Ghannam, D CharronTissue Antigens|July 25, 2015
Allogenic benefit in stem cell therapy: cardiac repair and regenerationR Al-Daccak, D CharronMolecular Immunology|March 24, 2004
Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition patternK Faé, J Kalil, A Toubert, et al.Tissue Antigens|January 7, 2012
Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never againA Toubert, S Glauzy, C Douay, et al.European Cytokine Network|January 1, 1994
Evidence for GM-CSF receptor expression in synovial tissue. An analysis by semi-quantitative polymerase chain reaction on rheumatoid arthritis and osteoarthritis synovial biopsiesF Berenbaum, G Rajzbaum, B Amor, et al.British Journal of Haematology|December 12, 2001
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patientsS Maury, J Y Mary, C Rabian, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Double-blind, placebo-controlled lithium treatment in chemotherapy induced aplasia for AML: reduced antibiotic requirementS Collado, D Charron, L DegosPageof 27